Navidea Biopharmaceuticals (NAVB) News Today $0.0001 0.00 (0.00%) (As of 12/20/2024 04:04 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Navidea Biopharmaceutical (OTC:NAVB) Stock Quotes, Forecast and News SummaryOctober 28, 2024 | benzinga.comNavidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024July 3, 2024 | businesswire.comNavidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024June 20, 2024 | businesswire.comSK Biopharmaceuticals Co. Ltd.May 25, 2024 | wsj.comDay One Biopharmaceuticals, Inc. Common Stock (DAWN)May 3, 2024 | nasdaq.comNavidea Biopharmaceutical Stock (OTC:NAVB), Short Interest ReportFebruary 23, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Insider TradesFebruary 22, 2024 | benzinga.comCentral Ohio public company voluntarily deregisters stockJanuary 29, 2024 | bizjournals.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 26, 2024 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 26, 2024 | finance.yahoo.comSuzhou Zelgen Biopharmaceuticals Co Ltd (688266)January 11, 2024 | investing.comNavidea settles litigation with Capital Royalty, stock rallies 30%December 1, 2023 | msn.comNavidea Biopharmaceuticals, CRG Settle All Ongoing LitigationDecember 1, 2023 | markets.businessinsider.comNavidea Biopharmaceuticals Inc NAVBNovember 1, 2023 | morningstar.comNavidea Biopharmaceuticals faces delisting from NYSE American, plans to move to OTC marketsOctober 26, 2023 | investing.comNYSE American halts trading on Navidea stock after delisting recommendedOctober 6, 2023 | bizjournals.comNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockOctober 5, 2023 | finance.yahoo.comNYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)October 5, 2023 | tmcnet.comNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAugust 10, 2023 | finance.yahoo.comNYSE American starts to delist Navidea stock, company to appealAugust 1, 2023 | finance.yahoo.comWhy Navidea Biopharmaceuticals Shares Are NosedivingJuly 31, 2023 | benzinga.comNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesJuly 31, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationJuly 28, 2023 | finance.yahoo.comNYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)July 28, 2023 | businesswire.comNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerJuly 28, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownJuly 13, 2023 | finance.yahoo.comDublin biotech proposes reverse stock split, stock-for-debt swapJuly 6, 2023 | bizjournals.comNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsJune 30, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common StockJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateJune 7, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives NYSE American NoticeJune 2, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at MarketMay 22, 2023 | finance.yahoo.comNavidea Biopharma (NAVB) Earnings Dates & ReportsMay 15, 2023 | investing.comNavidea promotes Michael Sherman Blue to CMO postMay 11, 2023 | msn.comNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for CommunicationsMay 8, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of CreditApril 27, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694April 13, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps DownMarch 30, 2023 | businesswire.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | finance.yahoo.comQ4 2022 Navidea Biopharmaceuticals Inc Earnings CallMarch 22, 2023 | finance.yahoo.comNavidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial ResultsMarch 21, 2023 | finance.yahoo.comNavidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business UpdateMarch 15, 2023 | finance.yahoo.comNAVB.PH - | Stock Price & Latest News | ReutersJanuary 24, 2023 | reuters.comNavidea stock soars ~25% on upcoming US patent linked to cancer drug pipelineJanuary 3, 2023 | msn.comNavidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy PipelineJanuary 3, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q3 2022 Earnings Call TranscriptDecember 28, 2022 | finance.yahoo.comNavidea Biopharmaceuticals Files Appeal in CRG CaseNovember 30, 2022 | finance.yahoo.comNavidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid ArthritisNovember 28, 2022 | finance.yahoo.com Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… NAVB Media Mentions By Week NAVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAVB News Sentiment▼0.000.60▲Average Medical News Sentiment NAVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAVB Articles This Week▼00▲NAVB Articles Average Week Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vaxxinity News Today Ampio Pharmaceuticals News Today eFFECTOR Therapeutics News Today Alvotech News Today BriaCell Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NAVB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAVB Stock Alerts